| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.17 | 0.4 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |